RenovoRx Inc. (RNXT)
RenovoRx Statistics
Share Statistics
RenovoRx has 36.57M shares outstanding. The number of shares has increased by 48.49% in one year.
| 36.57M |
| 48.49% |
| 48.18% |
| 4.06% |
| n/a |
| 552 |
| 0.39% |
Short Selling Information
The latest short interest is 262.38K, so 0.72% of the outstanding shares have been sold short.
| 262.38K |
| 0.72% |
| 0.75% |
| 2.28 |
Valuation Ratios
The PE ratio is -32.6 and the forward PE ratio is -4.15. RenovoRx's PEG ratio is 1.63.
| -32.6 |
| -4.15 |
| 6681.35 |
| 0.4 |
| 64.16 |
| -31.44 |
| 1.63 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for RenovoRx.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.1, with a Debt / Equity ratio of 0.06.
| 4.1 |
| 4.1 |
| 0.06 |
| -0.03 |
| -0.03 |
| -28.57 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $4,300 |
| $-881,400 |
| 10 |
| 0.01 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by 33.33% in the last 52 weeks. The beta is 1.12, so RenovoRx's price volatility has been higher than the market average.
| 1.12 |
| 33.33% |
| 1.06 |
| 1.11 |
| 72.69 |
| 141,898 |
Income Statement
In the last 12 months, RenovoRx had revenue of 43K and earned -8.81M in profits. Earnings per share was -0.4.
| 43K |
| 43K |
| -10.97M |
| -8.81M |
| -10.97M |
| -10.97M |
| -0.4 |
Balance Sheet
The company has 7.15M in cash and 278K in debt, giving a net cash position of 6.88M.
| 7.15M |
| 278K |
| 6.88M |
| -50.22M |
| 16.01M |
| 14.01M |
Cash Flow
In the last 12 months, operating cash flow was -9.13M and capital expenditures -12K, giving a free cash flow of -9.14M.
| -9.13M |
| -12K |
| -9.14M |
| -0.04 |
Margins
Gross margin is 100%, with operating and profit margins of -25511.63% and -20497.67%.
| 100% |
| -25511.63% |
| -20497.67% |
| -20497.67% |
| -25511.63% |
| -25511.63% |
| -21248.84% |
Dividends & Yields
RNXT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for RNXT is $7.25, which is 417.9% higher than the current price. The consensus rating is "Strong Buy".
| $7.25 |
| 417.9% |
| Strong Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 4.95 |
| 3 |